The Evidence Base Post 12 November 2024

Countdown to ISPOR Europe 2024

Joanne Walker

The ISPOR—The Professional Society for Health Economics and Outcomes Research (ISPOR) Europe 2024 conference will take place November 17–20, 2024 in Barcelona, Spain and focus on the theme, ‘Generating Evidence Toward Health and Well-Being’.

Co-chaired by Yannis Natsis (European Social Insurance Platform [ESIP], Belgium), Patrice Verpillat (European Medicines Agency, The Netherlands) and Anne Willemesen (Dutch National Healthcare Institute, The Netherlands), attendees have a choice of learning formats, including Spotlight Sessions, Workshops, Issue Panels, Educational Symposia and Exhibit Hall Theaters, covering 12 different topics within HEOR. Catch up on our ‘Navigating the conference program’ articles, where we highlight our picks of sessions and posters from some of these topic areas:

Our partners

The Evidence Base is delighted to be working with several partners to bring coverage of their sessions and posters. If you are at the ISPOR Europe 2024, be sure explore their research and sessions and stop by their booths.

Access Infinity – Booth 800

Meet Keshav Nagaraja (Managing Director - Digital, Access Infinity) and colleagues to learn about their latest capabilities, including the Evidence Hub, which aims to transform evidence management through AI.

Read more about Evidence Hub in the Guest Column, "From complexity to clarity with AI: transforming evidence management with Evidence Hub."

Aetion – Booth 1212

Ulka Campbell (Head of Scientific Strategy), Jeremy Rassen (Co-founder & Interim CEO) and Sebastian Schneeweiss (Co-Founder & Senior Advisor, Aetion; Professor of Medicine, Harvard Medical School) will join Aetion colleagues as they share their latest research in the application of RWE.

Catch up on this recent interview with Ashley Jaksa (Scientific Research & Strategy, Aetion) and Melinda Hanisch (Global Evidence and Regulatory Policy, Merck Sharp & Dohme [MSD]) to learn more about their research being presented at ISPOR Europe 2024 exploring the current practices in using RWE for HTA reassessments (HTAR) across six major HTA agencies.

BC Platforms – Booth 812

The BC Platforms team will be at ISPOR Europe 2024 to discuss how RWD insights can help drive evidence-based decision-making, personalize treatment approaches, and advance research and development. Read more about the evolving role of RWD in deriving actionable insights for tailored treatment strategies in this Guest Column.

Bionical Emas

I’m looking forward to hearing from Rakesh Davda (Vice President, Real World Evidence Solutions) about the research “Navigating Real-World Data Collection From Early Access Programs in the UK: An Underutilized Opportunity" during Poster Session 1 (12:30pm –13:30pm) on Monday November 18.

Cardinal Health – Booth 606

Bruce Feinberg (Vice President and Chief Medical Officer) will join colleagues Jeff Hoffman and Liz Mearns. Selected poster being presented by Cardinal Health include:

Therapeutic decision-making for patients with sickle cell disease and how research findings influence the potential use of Mitapivat (Monday November 18, 6:00pm – 7:00 pm; Poster Session 2)
Current Epcoritamab plus Rituximab and Lenalidomide (R2) perceptions for patients with relapsed/refractory follicular lymphoma (Tuesday November 19, 6:00pm – 7:00 pm; Poster Session 4)
Oncologists’ perceptions of Nivolumab plus Ipilumumab (NIVO + IPI) as first-line treatment for microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer (Wednesday November 20, 9:00am – 10:00 am; Poster Session 5)

Cencora – Booth 621

A key session from Cencora will be the Educational Symposium “Ready for 2025? How Lessons Learned From National System Reforms Can Guide Our Response to the New EU HTA Regulations”. Moderator Herbert Altmann (Cencora, UK) will be joined by Iga Lipska (Medical University of Gdańsk, Poland), François Meyer (FIPRA Public Affairs, France), Oriol Solà-Morales (Health Innovation Technology Transfer, Spain), and Mihai Rotaru (European Federation of Pharmaceutical Industries and Associations, Belgium) as they provide exclusive insights into JCA launching in January 2025 and its impact on European healthcare innovation evaluation.

Are you ready EU HTAR launch in January 2025? Register for our webinar on Tuesday December 3 to hear experts from this session discuss the critical success factors to implementing this new regulation.

Genesis Research Group – Booth 412

The team from Genesis Research Group will be presenting several posters and taking part in sessions, including the Issue Panel “Precision or Perception: Strategic Drug Pricing Anchored on Evidence” (Monday November 18, 10:15am – 11:15am) and the Exhibit Hall Theater session "Planning With Payer Insights: Even the Best Economic Models Need Validation" (Tuesday November 19, 11:45am – 12:15pm).

LCP Health Analytics – Booth 503

Jonathan Pearson-Stuttard (artner & Head of Health Analytics), Catrin Treharne (Principal and Health Economics Lead) and Ben Bray (Partner and Evidence Generation Lead) will represent the LCP Health Analytics team at ISPOR Europe 2024. A highlight for me will be Exhibit Hall Theater Session (Tuesday November 19, 12:45pm – 1:45pm) one “Using Generative AI Methods for Evidence Generation and Health Technology Assessment: Perspectives From NICE and Industry” where Bray will be joined by Stephen Duffield (NICE, UK) to discuss the evolving capabilities of generative AI, including large language models like ChatGPT, in RWE generation and healthcare decision-making.

The Evidence Base at the ISPOR Europe 2024

Be sure to follow The Evidence Base on LinkedIn to stay up-to-date with our daily coverage. And register to access our premium content and receive regular updates and newsletters.

As a media partner for ISPOR Europe 2024, my colleagues from The Evidence Base teams will also be at the event. You can catch Phil Garner in the exhibit hall as he meets current and future sponsoring partners whilst Katie McCool will be attending many of the sessions, to provide insights and coverage for our readers. Laura Dormer will also be at the conference, providing her exclusive take homes from the plenary session as well as meeting with the authors and Editorial Board of the Journal of Comparative Effectiveness Research. If you see us at the conference, be sure to say hello. And if you would like to set up a meeting to talk through opportunities to become a sponsor, contribute to The Evidence Base, or to publish in the Journal of Comparative Effectiveness Research, then please contact us here.